Abstract
T cells are considered autoimmune effectors in juvenile idiopathic arthritis (JIA), but the antigenic cause of arthritis remains elusive. Since T cells comprise a significant proportion of joint-infiltrating cells, we examined whether the environment in the joint could be shaped through the inflammatory activation by T cells that is independent of conventional TCR signaling. We focused on the analysis of synovial fluid (SF) collected from children with oligoarticular and rheumatoid factor-negative polyarticular JIA. Cytokine profiling of SF showed dominance of five molecules including IL-17A. Cytometric analysis of the same SF samples showed enrichment of αβT cells that lacked both CD4 and CD8 co-receptors [herein called double negative (DN) T cells] and also lacked the CD28 costimulatory receptor. However, these synovial αβT cells expressed high levels of CD31, an adhesion molecule that is normally employed by granulocytes when they transit to sites of injury. In receptor crosslinking assays, ligation of CD31 alone on synovial CD28nullCD31+ DN αβT cells effectively and sufficiently induced phosphorylation of signaling substrates and increased intracytoplasmic stores of cytokines including IL-17A. CD31 ligation was also sufficient to induce RORγT expression and trans-activation of the IL-17A promoter. In addition to T cells, SF contained fibrocyte-like cells (FLC) expressing IL-17 receptor A (IL-17RA) and CD38, a known ligand for CD31. Stimulation of FLC with IL-17A led to CD38 upregulation, and to production of cytokines and tissue-destructive molecules. Addition of an oxidoreductase analog to the bioassays suppressed the CD31-driven IL-17A production by T cells. It also suppressed the downstream IL-17A-mediated production of effectors by FLC. The levels of suppression of FLC effector activities by the oxidoreductase analog were comparable to those seen with corticosteroid and/or biologic inhibitors to IL-6 and TNFα. Collectively, our data suggest that activation of a CD31-driven, αβTCR-independent, IL-17A-mediated T cell-FLC inflammatory circuit drives and/or perpetuates synovitis. With the notable finding that the oxidoreductase mimic suppresses the effector activities of synovial CD31+CD28null αβT cells and IL-17RA+CD38+ FLC, this small molecule could be used to probe further the intricacies of this inflammatory circuit. Such bioactivities of this small molecule also provide rationale for new translational avenue(s) to potentially modulate JIA synovitis.
Highlights
Juvenile idiopathic arthritis (JIA) is a highly prevalent rheumatic disease of childhood before the age of 16 years
There is exaggerated synovial inflammation compared to blood that is reflected by non-correspondence between plasma/serum and synovial fluid (SF) cytokine profiles [21]
Biological analysis of SF is a preferable approach to better understand the nature of synovitis in JIA [49]
Summary
Juvenile idiopathic arthritis (JIA) is a highly prevalent rheumatic disease of childhood before the age of 16 years. It is a genetic and clinical entity distinct from adult-onset rheumatoid arthritis (RA). Multiple HLA associations of JIA implicate involvement of T cells [2]. Oligoclonal expansions of these cells in blood and synovial fluid (SF) are well documented [3]. The antigenic driver(s) of oligoclonality, or antigenic cause(s) of JIA disease remain elusive. T cells play a role in JIA pathogenesis as they comprise a significant proportion of jointinfiltrating cells [4, 5]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have